Glenmede Trust’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Sell
1,995
-722
-27% -$120K ﹤0.01% 1174
2026
Q1
$570K Buy
2,717
+166
+7% +$41.7K ﹤0.01% 914
2025
Q4
$725K Buy
+2,551
New +$798K ﹤0.01% 826
2025
Q1
$590K Buy
2,247
+67
+3% +$18.1K ﹤0.01% 849
2024
Q4
$569K Buy
2,180
+100
+5% +$25.2K ﹤0.01% 894
2024
Q3
$484K Buy
2,080
+47
+2% +$9.65K ﹤0.01% 940
2024
Q2
$410K Buy
2,033
+246
+14% +$44.3K ﹤0.01% 973
2024
Q1
$306K Buy
1,787
+115
+7% +$21.4K ﹤0.01% 1052
2023
Q4
$363K Buy
+1,672
New +$287K ﹤0.01% 995
2020
Q4
Sell
-16
Closed -$3K 1975
2020
Q3
$3K Buy
16
+6
+60% +$1.26K ﹤0.01% 2204
2020
Q2
$1K Sell
10
-30
-75% -$5.74K ﹤0.01% 2354
2020
Q1
$6K Hold
40
﹤0.01% 2625
2019
Q4
$6K Buy
40
+31
+344% +$5.17K ﹤0.01% 2625
2019
Q3
$1K Sell
9
-7
-44% -$984 ﹤0.01% 2942
2019
Q2
$1K Hold
16
﹤0.01% 2977
2019
Q1
$1K Hold
16
﹤0.01% 2953
2018
Q4
$1K Buy
+16
New +$1.35K ﹤0.01% 2911
2018
Q3
Sell
-500
Closed -$43K 1736
2018
Q2
$43K Buy
500
+390
+355% +$35K ﹤0.01% 1489
2018
Q1
$7K Hold
110
﹤0.01% 2316
2017
Q4
$7K Buy
110
+71
+182% +$4.66K ﹤0.01% 2316
2017
Q3
$2K Hold
39
﹤0.01% 2591
2017
Q2
$1K Hold
39
﹤0.01% 2603
2017
Q1
$1K Sell
39
-26
-40% -$1.11K ﹤0.01% 2603
2016
Q4
$2K Buy
65
+1
+2% +$37 ﹤0.01% 2363
2016
Q3
$2K Buy
64
+25
+64% +$988 ﹤0.01% 2411
2016
Q2
$1K Sell
39
-10
-20% -$311 ﹤0.01% 2482
2016
Q1
$1K Hold
49
﹤0.01% 2527
2015
Q4
$1K Hold
49
﹤0.01% 2570
2015
Q3
$1K Buy
+49
New +$1.49K ﹤0.01% 2616

Other funds holding PODD

Glenmede Trust's PODD Position: Q2 2026 in Review

Glenmede Trust reduced its Insulet (PODD) stake by 27% in Q2 2026, selling an estimated $120K and leaving 1,995 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Glenmede Trust first reported a position in PODD in Q3 2015 and has held it in 29 quarters since. The position peaked at $725K in Q4 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Glenmede Trust held 1,995 shares of Insulet worth $304K as of Q2 2026.
  • Glenmede Trust sold 722 Insulet shares in Q2 2026, an estimated $120K.
  • Insulet made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1174 holding.
  • Glenmede Trust first reported a position in Insulet in Q3 2015 and has held it in 29 quarters since.
  • Glenmede Trust's Insulet position peaked at $725K in Q4 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.